Dr. Lal PathLabs Future Growth
Future criteria checks 3/6
Dr. Lal PathLabs is forecast to grow earnings and revenue by 15.8% and 10.9% per annum respectively. EPS is expected to grow by 15.8% per annum. Return on equity is forecast to be 22.3% in 3 years.
Key information
15.8%
Earnings growth rate
15.8%
EPS growth rate
Healthcare earnings growth | 26.3% |
Revenue growth rate | 10.9% |
Future return on equity | 22.3% |
Analyst coverage | Good |
Last updated | 30 Aug 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 31,586 | 5,891 | 6,609 | N/A | 16 |
3/31/2026 | 28,114 | 5,075 | 5,898 | N/A | 22 |
3/31/2025 | 24,982 | 4,302 | 5,057 | N/A | 21 |
6/30/2024 | 22,875 | 3,815 | N/A | N/A | N/A |
3/31/2024 | 22,266 | 3,577 | 4,779 | 5,353 | N/A |
12/31/2023 | 21,722 | 3,298 | N/A | N/A | N/A |
9/30/2023 | 21,227 | 3,013 | 4,767 | 5,198 | N/A |
6/30/2023 | 20,552 | 2,638 | N/A | N/A | N/A |
3/31/2023 | 20,169 | 2,388 | 4,115 | 4,560 | N/A |
12/31/2022 | 20,114 | 2,435 | N/A | N/A | N/A |
9/30/2022 | 20,189 | 2,480 | -824 | 3,884 | N/A |
6/30/2022 | 19,835 | 2,713 | N/A | N/A | N/A |
3/31/2022 | 20,874 | 3,448 | -294 | 4,467 | N/A |
12/31/2021 | 20,329 | 3,669 | N/A | N/A | N/A |
9/30/2021 | 19,884 | 4,041 | 4,609 | 5,327 | N/A |
6/30/2021 | 19,219 | 3,944 | N/A | N/A | N/A |
3/31/2021 | 15,813 | 2,916 | 3,386 | 3,982 | N/A |
12/31/2020 | 14,520 | 2,407 | N/A | N/A | N/A |
9/30/2020 | 13,275 | 2,003 | 2,259 | 2,821 | N/A |
6/30/2020 | 12,612 | 1,955 | N/A | N/A | N/A |
3/31/2020 | 13,304 | 2,259 | 2,043 | 2,839 | N/A |
12/31/2019 | 13,298 | 2,405 | N/A | N/A | N/A |
9/30/2019 | 12,944 | 2,322 | 2,199 | 2,619 | N/A |
6/30/2019 | 12,463 | 2,086 | N/A | N/A | N/A |
3/31/2019 | 12,034 | 1,992 | 1,765 | 2,185 | N/A |
12/31/2018 | 11,691 | 1,923 | N/A | N/A | N/A |
9/30/2018 | 11,393 | 1,825 | N/A | N/A | N/A |
6/30/2018 | 10,999 | 1,761 | N/A | N/A | N/A |
3/31/2018 | 10,569 | 1,707 | N/A | 1,971 | N/A |
12/31/2017 | 10,100 | 1,617 | N/A | N/A | N/A |
9/30/2017 | 9,548 | 1,565 | N/A | N/A | N/A |
6/30/2017 | 9,389 | 1,586 | N/A | N/A | N/A |
3/31/2017 | 9,124 | 1,546 | N/A | 1,713 | N/A |
12/31/2016 | 8,902 | 1,576 | N/A | N/A | N/A |
9/30/2016 | 8,713 | 1,876 | N/A | N/A | N/A |
6/30/2016 | 8,249 | 1,413 | N/A | N/A | N/A |
3/31/2016 | 7,913 | 1,322 | N/A | 1,585 | N/A |
12/31/2015 | 7,654 | 1,201 | N/A | N/A | N/A |
3/31/2015 | 6,596 | 908 | N/A | 1,218 | N/A |
3/31/2014 | 5,579 | 763 | N/A | 980 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 539524's forecast earnings growth (15.8% per year) is above the savings rate (6.7%).
Earnings vs Market: 539524's earnings (15.8% per year) are forecast to grow slower than the Indian market (17.3% per year).
High Growth Earnings: 539524's earnings are forecast to grow, but not significantly.
Revenue vs Market: 539524's revenue (10.9% per year) is forecast to grow faster than the Indian market (10.1% per year).
High Growth Revenue: 539524's revenue (10.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 539524's Return on Equity is forecast to be high in 3 years time (22.3%)